The present study sought to compare nerve CSA in children with DSD to controls, and to children with CMT1A, with the hypothesis that the degree of nerve enlargement in DSD would exceed that of CMT1A, given its generally more severe clinical and neurophysiologic phenotype. The gene discussed is PMP22; the disease is disorder of sexual differentiation.